Return On Equity of NEXIEN BIOPHARMA, INC. from 30 Sep 2015 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NEXIEN BIOPHARMA, INC. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 31 Mar 2025.
  • NEXIEN BIOPHARMA, INC. Return On Equity for the quarter ending 31 Mar 2025 was 46%, a 44% decline year-over-year.
  • NEXIEN BIOPHARMA, INC. annual Return On Equity for 2024 was 74%, a 57% decline from 2023.
  • NEXIEN BIOPHARMA, INC. annual Return On Equity for 2023 was 171%, a 81% decline from 2022.
  • NEXIEN BIOPHARMA, INC. annual Return On Equity for 2022 was 884%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

NEXIEN BIOPHARMA, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 46% -37% -44% 01 Jan 2025 31 Mar 2025
Q4 2024 56% -44% -44% 01 Oct 2024 31 Dec 2024
Q3 2024 56% -84% -60% 01 Jul 2024 30 Sep 2024
Q2 2024 74% -97% -57% 01 Apr 2024 30 Jun 2024
Q1 2024 83% -122% -59% 01 Jan 2024 31 Mar 2024
Q4 2023 100% -247% -71% 01 Oct 2023 31 Dec 2023
Q3 2023 140% -454% -76% 01 Jul 2023 30 Sep 2023
Q2 2023 171% -713% -81% 01 Apr 2023 30 Jun 2023
Q1 2023 206% -1379% -87% 01 Jan 2023 31 Mar 2023
Q4 2022 348% -962% -73% 01 Oct 2022 31 Dec 2022
Q3 2022 594% -38603% -98% 01 Jul 2022 30 Sep 2022
Q2 2022 884% +33070% 01 Apr 2022 30 Jun 2022
Q1 2022 1585% +32406% 01 Jan 2022 31 Mar 2022
Q4 2021 1310% +13268% 01 Oct 2021 31 Dec 2021
Q3 2021 39197% +44914% 01 Jul 2021 30 Sep 2021
Q2 2021 -32186% -29516% -1106% 01 Apr 2021 30 Jun 2021
Q1 2021 -30821% -29003% -1595% 01 Jan 2021 31 Mar 2021
Q4 2020 -11958% -11058% -1229% 01 Oct 2020 31 Dec 2020
Q3 2020 -5718% -4887% -588% 01 Jul 2020 30 Sep 2020
Q2 2020 -2670% -2062% -340% 01 Apr 2020 30 Jun 2020
Q1 2020 -1818% -1445% -387% 01 Jan 2020 31 Mar 2020
Q4 2019 -899% -582% -183% 01 Oct 2019 31 Dec 2019
Q3 2019 -831% -683% -462% 01 Jul 2019 30 Sep 2019
Q2 2019 -607% -453% -293% 01 Apr 2019 30 Jun 2019
Q1 2019 -374% -194% -108% 01 Jan 2019 31 Mar 2019
Q4 2018 -318% -45% -17% 01 Oct 2018 31 Dec 2018
Q3 2018 -148% +841% +85% 01 Jul 2018 30 Sep 2018
Q2 2018 -154% +185% +54% 01 Apr 2018 30 Jun 2018
Q1 2018 -179% -286% -269% 01 Jan 2018 31 Mar 2018
Q4 2017 -273% -302% -1029% 01 Oct 2017 31 Dec 2017
Q3 2017 -989% -1020% -3264% 01 Jul 2017 30 Sep 2017
Q2 2017 -339% -373% -1111% 27 Mar 2017 30 Jun 2017
Q1 2017 106% +71% +198% 01 Jan 2017 31 Mar 2017
Q4 2016 29% -7.1% -20% 01 Oct 2016 31 Dec 2016
Q3 2016 31% -84% -73% 01 Jul 2016 30 Sep 2016
Q2 2016 34% 01 Apr 2016 30 Jun 2016
Q1 2016 36% 01 Jan 2016 31 Mar 2016
Q4 2015 36% 01 Oct 2015 31 Dec 2015
Q3 2015 116% 01 Jul 2015 30 Sep 2015

NEXIEN BIOPHARMA, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 74% -97% -57% 01 Jul 2023 30 Jun 2024
2023 171% -713% -81% 01 Jul 2022 30 Jun 2023
2022 884% +33070% 01 Jul 2021 30 Jun 2022
2021 -32186% -29516% -1106% 01 Jul 2020 30 Jun 2021
2020 -2670% -2062% -340% 01 Jul 2019 30 Jun 2020
2019 -607% -453% -293% 01 Jul 2018 30 Jun 2019
2018 -154% -127% -467% 01 Jul 2017 30 Jun 2018
2017 -27% -61% -181% 01 Jul 2016 30 Jun 2017
2016 34% 01 Jul 2015 30 Jun 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.